How cities can crush carcinogenic DBPs without compromising disinfection

When chlorine or chloramines hit raw water loaded with natural organic matter (NOM), the chemistry is predictable — and problematic. The reaction creates halogenated disinfection byproducts (DBPs) such as trihalomethanes (THMs) and haloacetic acids (HAAs) linked with carcinogenicity and reproductive effects (ScienceDirect).

Regulators draw the line: WHO and many authorities target TTHM ≤100 µg/L and HAA5 ≤60 µg/L (WHO 2017). In practice, those limits are routinely breached without deliberate control — because NOM (humic/fulvic acids, proteins, etc.) is the primary THM/HAA precursor (ScienceDirect).

The fix starts upstream: remove precursors before disinfection, then optimize disinfectant type, dose, and application point so residual chemistry doesn’t spike DBPs downstream.

NOM as DBP precursor

“Remove NOM before disinfection” is the first principle. Reviews of enhanced treatment show optimized coagulation can remove 20–60% of NOM and cut DBP formation by a similar proportion (PubMed). Bench and full‑scale takeaways are consistent: lower dissolved organic carbon (DOC) and UV254 going into the disinfectant basin gives proportionally lower THM and HAA yields.

Conventional trains that include coagulation, clarification, and filtration can be tuned for organics, not just turbidity. Adding a clarifier to maximize solids capture and pre‑cursor removal is standard practice in this context.

Enhanced coagulation results

“Enhanced coagulation” means pushing coagulant dose and pH toward NOM removal targets. One jar‑test in Ethiopia found alum removed <28% of TOC, whereas switching to ferric chloride (FeCl_3) with pH adjustment removed ~50% of TOC and UV254 (CiteDrive). A South African study observed ferric was “marginally more effective” at DOC removal than alum (SciELO).

EPA‑style guidance notes iron coagulants under optimized dosing cut DBP formation potential by ~20–60% (PubMed). In practice, operators run bench‑scale jar tests and step coagulant upward — sometimes 2× or more the conventional dose — until UV254 hits target. For many plants, that means aiming for ~1–2 mg/L DOC to halve DBP formation potential. Deploying modern coagulants with tight control is central to this push.

Numerically, raising alum doses to 20–30 mg/L and/or using PAC coagulant aids cut THM formation potential by over 50% in one pilot (CiteDrive). Conventional DOC removal might sit ~30–40%; enhanced regimes reach ~50–60% (CiteDrive; IWA Publishing). Many plants pair such programs with polyaluminum chloride aids. Smooth execution depends on precise feeds — an accurate dosing pump is not a luxury here.

Sand filtration and dual media

Post‑coagulation, sand filtration polishes remaining particulates so disinfectant meets fewer precursors. Plants routinely rely on dual‑media beds; for example, a sand/silica filter placed ahead of downstream contactors keeps NOM and DBP formation potential trending down.

GAC adsorption performance

Granular activated carbon (GAC) adds a powerful NOM adsorption step. In Busan (South Korea), three GAC contactors with empty bed contact time (EBCT) ~15–20 minutes reduced DOC a further 15–23% after sand filtration; overall, conventional treatment removed ~35–41% of influent DOC, but with GAC total DOC removal reached ~50–58% (IWA Publishing). One concrete snapshot: raw DOC ~2.7 mg/L → ~1.6 mg/L after coagulation plus filtration → ~1.3 mg/L after GAC (IWA Publishing).

Design parameters matter. Typical GAC filter depths are 3–4 m, with filtration rates 7–14 m/h yielding ~15–20 minutes of contact time (IWA Publishing). High‑iodine‑number carbons (~1000 mg/g) last longer, and biologically active layers further biodegrade organics over time. In field data, well‑operated GAC systems can remove 5–10 kg DOC per m³ of carbon over its life, and virgin GAC has removed ~52 kg TTHM per 300 m³ filter run (IWA Publishing).

Capacity does decline: DOC removal efficiency can fall from ~80% initially to <10% after 2–3 years, prompting carbon replacement or reactivation (IWA Publishing). As adsorption beds, activated carbon contactors often double the DOC removal achieved by coagulation alone (IWA Publishing).

Membrane and oxidation options

Membrane filtration — notably nanofiltration (NF) and reverse osmosis (RO) — rejects NOM almost completely, but is costly and energy‑intensive; it tends to be used for high‑value supply (e.g., bottle plants). Utilities weighing this path typically evaluate a platform of nanofiltration or broader membrane systems against lifecycle cost.

Ozonation breaks aromatic NOM bonds and increases biodegradability, and pre‑ozonation before GAC often halves THM precursors; however, ozone also oxidizes bromide to bromate (a regulated DBP), so it must be carefully managed (PubMed). A review cautions that advanced pre‑oxidants are “effective” but raise concerns about bromate and highly brominated DBPs (PubMed). Advanced oxidation processes (UV/H₂O₂) likewise break down NOM, with cost/outcome varying by source water.

Disinfectant selection and sequence

Choice matters. Using monochloramine (combined chlorine) instead of free chlorine can reduce THM and HAA formation by an order of magnitude; Ontario notes chloramination yields “an order of magnitude less THM and HAA formation than free chlorine” (Ontario). In practice, switching a system’s secondary disinfectant to chloramines typically drives TTHM down by ~80–90% (as implied by that “10×” statement). Trade‑offs include monitoring for nitrosamines (NDMA) and nitrification (Ontario). Many utilities use chlorine for primary disinfection and a chloramine residual in distribution (Ontario).

Chlorine dioxide (ClO₂) is a strong disinfectant producing virtually no THM or HAA because it doesn’t chlorinate organics; it forms chlorite/chlorate byproducts and requires stringent control. In practice, utilities sometimes apply ClO₂ as an intermediate oxidant to minimize THMs, though such operations are less common in Indonesia.

Ozone is an excellent pre‑disinfectant (no residual THMs), but in bromide waters it makes bromate; UV disinfection produces no chlorinated DBPs at all but provides no residual, so it is often paired with a small chlorine or chloramine dose. Without solid numeric sources here, note that any reduction in chlorine exposure (dose×contact) cuts DBP formation proportionally. For systems integrating UV, a purpose‑built ultraviolet unit fills that role.

Dose, contact time, pH

Point of application is decisive. Eliminating or delaying pre‑chlorination — moving chlorine feed from raw water (where NOM is highest) to post‑filtration — can significantly reduce THM formation, sometimes by over 50% (Ontario). Many plants achieve these reductions by switching to post‑chlorination, often with only minor adjustments to meet CT requirements.

Optimized dosing aims for required CT (residual concentration × contact time) using as little chlorine as needed. That can mean maintaining a lower finished‑water residual (e.g., 0.2–0.5 mg/L) and relying on booster chlorination in the network; both strategies curb DBP formation by reducing excess exposure. Tighter metering via a dosing pump helps hold that line.

pH control is another lever. THM/HAA yields depend on pH during chlorination; generally, higher pH tends to suppress THM formation (up to a point) because HOCl/ClO– speciation and kinetics shift. Operators may raise finished‑water pH to ~8.0 to minimize THMs; in some waters, lowering pH from 8.0 to 6.5 can roughly double THM formation. The tuning affects corrosion control and may raise the relative HAA‑5 fraction.

Maintaining a residual via monochloramine both extends protection and reduces THM formation over time; a switch to chloramines “should result in a decrease in THMs and HAAs,” though high THMs formed upstream will not vanish (Ontario).

Case data and outcomes

Results are measurable. In comparative treatment trains, delaying chlorination and adding chloramination cut TTHM in finished water by over 50–80%. In Busan, conventionally treated water with filtration plus GAC ended with DOC 1.3–1.6 mg/L (IWA Publishing), implying TTHM <20 µg/L (well below many standards) for typical Asian waters. Conversely, plants with pre‑chlorination and no GAC saw TTHMs often in tens of µg/L per mg/L DOC. In New York and elsewhere, switching to chloramines routinely halved or better the THM levels in distribution.

The Ethiopian plant that shifted to FeCl_3‑enhanced coagulation (50% TOC removal) reported a marked drop in THM formation compared to alum‑only pretreatment (CiteDrive). Overall, models show roughly linear THM yield with residual DOC: for example, 1 mg/L DOC often yields ~20 µg/L TTHMs under medium‑chlorine CT; halving DOC roughly halves THMs.

At the portfolio level, compliance is tightening. A review notes that in China vs. the US, stricter THM limits cut compliance from 90%→60% of plants, underscoring the need for robust controls and alternative disinfectants (ResearchGate).

Putting the barriers together

The multi‑barrier approach is clear in the data: coagulation/filtration followed by GAC and/or oxidation can collectively remove well over half of NOM (PubMed; IWA Publishing). Every 1 mg/L reduction in DOC can cut THM formation by roughly dozens of µg/L (depending on water); in the Ethiopian case, ~50% TOC removal translated to much slower THM generation downstream.

Designers quantify success in two simple outputs: DBP precursor removals (%) and final TTHM concentrations (µg/L). Hitting combined 50–60% DOC reduction (CiteDrive; IWA Publishing) and then minimizing chlorine exposure — often via chloramines — is the pattern that consistently delivers. For plants building out the train, GAC beds, careful coagulation control, and targeted upgrades to disinfection equipment are the levers that move compliance.